You are here

  • Home
  • Archive
  • Volume 30, Issue 11
  • DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymera…

Citation Tools

Article menu

Download PDFPDF

XML
Clinical trial
DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
McMullen M, Karakasis K, Loembe B, et al
DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment
International Journal of Gynecologic Cancer 2020;30:1824-1828.